Tumor-Associated With Amyloidosis - Symptoms and Treatment

Introduction:

Tumor-associated amyloidosis is a subset of amyloidosis that occurs related to neoplastic diseases. The association between amyloidosis and tumors is particularly noted in plasma cell dyscrasias (groups of disorders in which the body makes too many plasma cells), such as multiple myeloma. Tumor-associated amyloidosis is a condition where abnormal proteins called amyloids build up in the tissues or organs due to any cancer. These proteins accumulate because the cancer cells produce too much of abnormal proteins. When the amyloid proteins get deposited in the organs, such as kidneys, liver, and nerves, cause these organs to stop working properly. Diagnosing and treating the condition may help prevent life-threatening complications. Dealing with the condition requires a team of medical specialists to provide the best care and improve patient outcomes. The article discusses tumors associated with amyloidosis, its symptoms, diagnosis, and treatment.

What Is Amyloidosis?

Amyloidosis is a group of diseases characterized by the abnormal accumulation of amyloid proteins in tissues and organs. These amyloid proteins are misfolded and can deposit in various body parts, affecting their normal function. The condition can affect a single organ or multiple organs. Two types of amyloidosis include primary and secondary amyloidosis.

What Are the Tumors Associated With Amyloidosis?

Tumor-associated amyloidosis involves the overproduction of amyloid proteins by non-cancerous cells. This gets deposited in the tissues or organs. This can happen with certain cancers. The common tumors associated with amyloidosis are as follows:

• Hematologic Malignancies: These are blood-related malignancies. The common hematologic malignancies associated with amyloidosis are as follows:

  • Multiple Myeloma: It is a blood-related cancer that is present in the bone marrow plasma cells. The common organs affected are the kidneys, heart, liver, and nerves. It is associated with primary amyloidosis. The overproduction of immunoglobulin light chains by malignant plasma cells, which can misfold and fold amyloid fibrils.

  • Waldenstrom Macroglobulinemia: It is a rare type of lymphoma where the body produces excessive amounts of proteins called immunoglobulin M (IgM). These excessive amounts of proteins can form amyloid deposits.

  • Non-Hodgkin Lymphoma: It is a group of blood cancers that affect the lymphatic system. The common organs affected include the kidneys, heart, liver, and gastrointestinal tract. Malignant B cells in the lymphatic system produce proteins that can form amyloid deposits in various organs.

• Solid Tumors:

  • Medullary Thyroid Carcinoma: It is a type of thyroid cancer. In this condition, the cancer cells produce a hormone called calcitonin which can form amyloid deposits in the thyroid gland.

  • Hodgkin Lymphoma: It is a type of cancer that starts in the lymphatic system. Chronic inflammation from cancer increases the production of certain proteins that can convert into amyloid.

  • Renal Cell Carcinoma: It is a type of kidney cancer. During renal cell carcinoma, the inflammation from the tumor can lead to increased production of amyloid-forming proteins.

• Other Blood Cancers:

  • Chronic Lymphocytic Leukemia (CLL): It is a type of leukemia (blood cancer) that affects the white blood cells. During this condition, the leukemia cells produce proteins that can turn into amyloid.

What Are the Common Symptoms of Tumor-Associated Amyloidosis?

Tumor-associated amyloidosis can present a wide range of symptoms based on the organ affected by the amyloid deposits. The common signs and symptoms of tumor-associated amyloidosis are as follows:

• General Symptoms: The affected person may feel unusually tired and weak. This symptom is common in both cancer and amyloidosis. The other symptom is unintentional weight loss. This can be due to underlying cancer or the systemic effects of amyloidosis.

• Renal Involvement: If the kidney is involved, the excess protein in the urine can lead to foamy urine. Due to protein loss, there may be swelling in the legs and ankles. In some cases, there may be a loss of kidney function, causing an accumulation of waste products in the body. This can cause kidney failure.

• Heart Involvement: The thickening and stiffening of the heart walls may cause heart failure or cardiomyopathy. There may be irregular heartbeats, which can cause dizziness or palpitations. In severe cases, heart failure can cause shortness of breath, fatigue, and swelling in the legs and abdomen.

• Nervous System Involvement: Issues with autonomic functions, such as blood pressure regulation, can cause fainting and dizziness. Peripheral symptoms include numbness, tingling, and hand and foot pain.

• Liver and Spleen Involvement: The symptoms include an enlarged liver and spleen, which can cause pain in the upper right abdomen and fullness or pain in the upper left abdomen.

• Gastrointestinal Involvement: Due to amyloid deposits, bowel habits may change. The difficulty in absorbing nutrients can lead to weight loss and nutritional deficiencies.

• Skin and Soft Tissue Involvement: There can be easy bruising, and the formation of purple spots on the skin can be caused by bleeding underneath the skin.

How Is Tumor-Associated Amyloidosis Diagnosed?

Clinical evaluation, laboratory tests, imaging studies, and tissue biopsy can manage tumor-associated amyloidosis. The diagnosis process of the condition is described below:

• Clinical Evaluation: The healthcare provider may take a detailed medical history of the patient to identify symptoms, such as fatigue, weight loss, and organ dysfunction. They may physically examine the patient for signs of edema, enlarged organs, and skin changes.

• Laboratory Tests: The healthcare provider may perform a complete blood count test to check for blood abnormalities and serum protein electrophoresis to detect abnormal monoclonal proteins.

• Urine Tests: This test is performed to measure proteinuria and renal function.

• Imaging Tests: The healthcare provider may perform echocardiography to assess the heart's function and detect amyloid deposits in the heart, ultrasound to detect spleen and liver enlargement, and magnetic resonance imaging (MRI) to see amyloid deposits in the organs like the heart and liver.

• Tissue Biopsy: The less invasive method to take tissue for amyloid detection.

What Are the Treatment Options for Managing Tumor-Associated Amyloidosis?

The treatment options include chemotherapy, targeted therapies, and supportive care. The treatment process is described below:

• Chemotherapy is performed in the case of hematologic malignancies. For some patients, high-dose chemotherapy followed by a stem cell transplant is effective. Targeted therapy, including drugs such as immunomodulatory drugs (Lenalidomide) and monoclonal antibodies, can manage these patients.

• In the case of solid tumors, surgery is done to remove the primary tumor, which can reduce amyloid production. It will be followed by chemotherapy and radiation therapy.

• Supportive care is essential to improve the patient's quality of life and manage symptoms effectively.

Conclusion:

Tumor-associated amyloidosis is a multifaceted condition in which abnormal amyloid proteins are deposited. These can be associated with several tumors, such as multiple myeloma. A comprehensive approach is essential for effective management and reducing the severity of symptoms. Continuous advancements and research in medical science are critical to improving the prognosis of the condition.